EU Post-Market Surveillance: How Doing More Than Minimum Will Benefit Medtech Manufacturers
Post-market surveillance requirements apply to all products under the EU’s Medical Device Regulation. Companies would do well to evaluate the additional benefits PMS can offer them, leading devices expert Bassil Akra explained during a recent interview.
You may also be interested in...
The European Commission’s proposal to extend transition timelines for legacy devices in the context of the Medical Device Regulation is already on the move. There are still questions, however, about whether a fast-track adoption is in the best interests of the medtech sector.
A review of expert panel opinions related to high-risk medical devices shows no challenges yet by notified bodies to their findings.
There had been handful of warning signals against well-known notified bodies designated against the MDR. Why were they there and why have they just been removed?